Robert Axtell

Robert Axtell

Company: Oklahoma Medical Research Foundation

Job title: Associate Member


Biomarkers & Environmental Factors that Can Predict Prognosis & Treatment Response in Multiple Sclerosis 3:30 pm

Developing precision medicine approaches for hard-to-treat autoimmune patients What is the immune cell phenotype of the individual patient? Environmental factors and their influence on MS patientsRead more

day: Day Two

Panel Discussion:Mapping the Therapeutic Target Landscape for B-Cell Mediated Autoimmune Disease & T-Cell Dependent Autoantibody Responses 9:30 am

Assessing the depletion of B-cells with anti-CD20 monoclonal antibodies Exploring how to best target CD8 T suppressor cells Discussing the various autoantigen specific B cell depleting and modulating therapies (CAART, BTK inhibitors, anti-CD20), targeting T-cell co-stimulatory pathways (CD40/CD40L, CD28/CTLA-4, OX40, ICOS, PD-1), and subduing autoantibody (FcRn inhibitors) approachesRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.